Vor Biopharma Inc (VOR)
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
Alvotech (ALVOW)
Main Results of 2025 Annual and Extraordinary General Meeting
Alvotech (ALVO)
Niðurstaða aðalfundar Alvotech árið 2025
Alvotech (ALVO)
Main Results of 2025 Annual and Extraordinary General Meeting
InVitae Corp (NVTAQ)
Kodiak Sciences to Present KSI-101 Highlights at 2025 Congress of the International Ocular Inflammation Society
9 Meters Biopharma, Inc. (NMTRQ)
Aaron Sorkin Working On “The Social Network Part II” — Everything We Know So Far
TEVA (TEVA)
Teva Pharmaceutical Industries Ltd. - Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025
Teva Pharmaceutical Industries Limited (TEVA)
Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025
Reviva Pharmaceuticals Holdings Inc. (RVPHW)
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
Reviva Pharmaceuticals Holdings Inc. (RVPH)
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering